US equities |
NVDA $239.24 ▲+0.14% MU $1,045.56 ▼-1.73% SPCX $171.92 ▲+0.49% AMD $649.42 ▲+2.80% MRVL $287.01 ▲+5.81% AVGO $375.81 ▲+3.67% INTC $112.50 ▼-3.18% MSFT $529.30 ▲+0.78%
FinancialContent

Latest News about PharmAla Biotech

Recent news which mentions PharmAla Biotech

PharmAla Biotech To Supply MDMA For Harvard's Maclean Hospital Clinical Trial
Tickers MDMA MDXXF NEWS
Tags News Benzinga Cannabis
From Benzinga
PharmAla Biotech Nabs First-Ever Canadian Approval To Provide MDMA Treatment Outside Clinical Setting
Tags Shaman Pharma Health Canada Special Access Program Market News
From Benzinga
New Clinical MDMA And Psilocybin Batches Head To Flourishing Psychedelics Market
Tickers IXHL MSSTF
Tags PharmAla Biotech Markets Market News
From Benzinga
Psyched Clinical Trials: Australian Univ. Pursues MDMA, MEAI Compound About To Set Off
Tickers CMND
Tags PharmAla Biotech Management Markets
From Benzinga
European Psychedelics Research Group Nabs $2M In Seed Funding As Clinical Research Picks Up Speed
Tickers MSSTF PSYGF
Tags Markets PharmAla Biotech Clerkenwell Health
From Benzinga